{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T22:15:22Z","timestamp":1715552122594},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,10,1]],"date-time":"1991-10-01T00:00:00Z","timestamp":686275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1991,10]]},"DOI":"10.1007\/bf03189970","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T03:31:33Z","timestamp":1281065493000},"page":"261-268","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacokinetics of triflusal and its main metabolite in rats and dogs"],"prefix":"10.1007","volume":"16","author":[{"given":"J.","family":"Ramis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Forn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03189970_CR1","first-page":"337","volume":"32","author":"J. Garc\u00eda Rafanell","year":"1977","unstructured":"Garc\u00eda Rafanell J., Morell J. (1977): L\u2019effect inhibiteur de l\u2019acide 2-acetoxy-4-trifluoromethyl benzoique (triflusal) et de l\u2019aspirine sur l\u2019aggregation des plaquettes chez l\u2019home et le rat Etude \u201cin vivo\u201d. Therapie, 32, 337\u2013344.","journal-title":"Therapie"},{"key":"BF03189970_CR2","first-page":"343","volume":"237","author":"J. Garc\u00eda Rafanell","year":"1979","unstructured":"Garc\u00eda Rafanell J., Planas J.M., Puig Parellada P. (1979): Biochemical profile of a new antithrombotic agent: triflusal (UR-1501). Arch. Int. Pharmacodyn. Ther., 237, 343\u2013350.","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"BF03189970_CR3","first-page":"135","volume":"7","author":"MJ. Sancho","year":"1985","unstructured":"Sancho MJ., Castellamau C., Villa L., et al. (1985): Effects of salicylate derivatives on cyclooxygenase interaction studies. Biol. din. Hematol., 7, 135\u2013143.","journal-title":"Biol. din. Hematol."},{"key":"BF03189970_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0160-5402(82)90039-0","volume":"7","author":"J. Garcia Rafanell","year":"1982","unstructured":"Garcia Rafanell J., Forn J. (1982): Intravenous arachidonate-induced respiratory distress: comparative study of three in vivo models for the measurement of antithrombotic activity. J. Pharmacol. Meth., 7, 231\u2013238.","journal-title":"J. Pharmacol. Meth."},{"key":"BF03189970_CR5","first-page":"13","volume":"9","author":"L. G\u00f3mez","year":"1987","unstructured":"G\u00f3mez L., Garcia Rafanell J., Forn J. (1987): Protective effect of triflusal and acetylsalicylic acid against arachidonic acid induced cerebrovascular occlusion in anaesthetized rats. Meth. Fin. Exp. Clin. Pharmacol., 9, 13\u201317.","journal-title":"Meth. Fin. Exp. Clin. Pharmacol."},{"key":"BF03189970_CR6","first-page":"357","volume":"7","author":"M.J. Dominguez","year":"1985","unstructured":"Dominguez M.J., Vacas H., Saez Y., et al. (1985): Effects of triflusal in patients with prosthetic heart valves. Clin. Ther., 7, 357\u2013360.","journal-title":"Clin. Ther."},{"key":"BF03189970_CR7","first-page":"105","volume":"9","author":"J. Pav\u00eda","year":"1987","unstructured":"Pav\u00eda J., De la Cruz, J.P., Gonzalez F., Sanchez de la Cuesta F. (1987): Efecto antiagregante plaquetario del triflusal en sangre total. Rev. Esp. Tromb. Hemost, 9, 105.","journal-title":"Rev. Esp. Tromb. Hemost"},{"key":"BF03189970_CR8","first-page":"11","volume":"7","author":"V. Rimbau","year":"1981","unstructured":"Rimbau V., Lopez R., Fernandez A., Forn J. (1981): Estudio farmacocin\u00e9tico del triflusal (UR-1501). Arch. Farmac. Toxicol., 7, 11\u201316.","journal-title":"Arch. Farmac. Toxicol."},{"key":"BF03189970_CR9","first-page":"198","volume":"13","author":"V. Rimbau","year":"1982","unstructured":"Rimbau V., Torralba A., Forn J. (1982): Estudios de distributi\u00f3n en rata y rat\u00f3n del trifhisal-C14 y de sus metabolitos. J. Pharmacol. (Paris), 13, 198\u2013199.","journal-title":"J. Pharmacol."},{"key":"BF03189970_CR10","first-page":"147","volume":"13","author":"V. Rimbau","year":"1982","unstructured":"Rimbau V., Forn J. (1982): Estudio mediante radiois\u00f3topes de la farmacocin\u00e9tica en la rata del triflusal, nuevo agente antitromb\u00f3tico. J. Pharmacol. (Paris), 13, 147.","journal-title":"J. Pharmacol."},{"key":"BF03189970_CR11","first-page":"597","volume":"14","author":"J. Ramis","year":"1983","unstructured":"Ramis J., Rimbau V., Sanchez M.S., Garc\u00eda Rafanell J., Forn J. (1983): Estudio farmacocin\u00e9tico del triflusal y dipiridamol tras su administrati\u00f3n simult\u00e1nea. J. Pharmacol. (Paris), 14, 597.","journal-title":"J. Pharmacol."},{"key":"BF03189970_CR12","unstructured":"Ramis J., Sanchez M.S., Forn J, (1984): Dypiridamole and triflusal pharmacokinetics after simultaneous administration in dogs. 9th International Congress of Pharmacology, London."},{"key":"BF03189970_CR13","first-page":"11","volume":"4","author":"M. Albors","year":"1987","unstructured":"Albors M., Castellamau C., Vila L., Sola J., Rutilant M.LL. (1987): Inhibition of thromboxane production and platelet function by triflusal in healthy volunteers. Rev. Farmac. Clin. Exp., 4, 11\u201316.","journal-title":"Rev. Farmac. Clin. Exp."},{"key":"BF03189970_CR14","volume-title":"PCNONLIN. User\u2019s Guide","author":"C.M. Meteler","year":"1985","unstructured":"Meteler C.M., Weiner D.L. (1985): PCNONLIN. User\u2019s Guide. Lexington, Statistical Consultants, Inc."},{"key":"BF03189970_CR15","volume-title":"Fundamentals of Clinical Pharmacokinetics","author":"J.G. Wagner","year":"1975","unstructured":"Wagner J.G. (1975): Fundamentals of Clinical Pharmacokinetics. Hamilton, Illinois, Drug Intelligence Publications."},{"key":"BF03189970_CR16","doi-asserted-by":"crossref","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"Gibaldi M., Perrier D. (1982): Pharmacokinetics. New York, Dekker."},{"key":"BF03189970_CR17","volume-title":"SPSS\/PC+ for the IBM PC\/XT\/AT","author":"M.J. Norusis","year":"1986","unstructured":"Norusis M.J. (1986): SPSS\/PC+ for the IBM PC\/XT\/AT. Chicago, SPSS Inc."},{"key":"BF03189970_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.2042-7158.1982.tb04216.x","volume":"34","author":"K. Iwamoto","year":"1982","unstructured":"Iwamoto K., Takei M., Watanabe J. (1982): Gastrointestinal and hepatic first-pass metabolism of aspirin in rats. J. Pharm. Pharmacol., 34, 176.","journal-title":"J. Pharm. Pharmacol."},{"key":"BF03189970_CR19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.2042-7158.1983.tb02871.x","volume":"35","author":"K. Iwamoto","year":"1983","unstructured":"Iwamoto K., Arakawa Y., Watanabe J. (1983): Gastrointestinal and hepatic first-pass effects of salicylamide in rats. J. Pharm. Pharmacol., 35, 687\u2013689.","journal-title":"J. Pharm. Pharmacol."},{"key":"BF03189970_CR20","first-page":"197","volume":"8","author":"V. Rimbau","year":"1982","unstructured":"Rimbau V., Fom J., Torralba A. (1982): Estudios de distributi\u00f3n y metabolismo del triflusal. Arch. Farmac. Toxicol., 8, 197\u2013200.","journal-title":"Arch. Farmac. Toxicol."},{"key":"BF03189970_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.2600580114","volume":"58","author":"P.A. Harris","year":"1969","unstructured":"Harris P.A., Riegelman S. (1969): Influence of the route of administration and the area under the plasma concentration-time curve. J. Pharm. Sci., 58, 71\u201375.","journal-title":"J. Pharm. Sci."},{"key":"BF03189970_CR22","unstructured":"Garc\u00eda Rafanell J., Gomez L., Forn J. (1984): Perfil bioqu\u00edmico de un nuevo antiagregante plaquetario (triflusal) y su incidencia en el binomio hiperactividad plaquetaria-enfermedad tromboemb\u00f3lica. Esplugues J. Ed. Pharmacology of the Vascular Wall. Universidad de Valencia, pp. 446."},{"key":"BF03189970_CR23","first-page":"155","volume":"284","author":"J. Garc\u00eda Rafanell","year":"1986","unstructured":"Garc\u00eda Rafanell J., Ramis J., Gomez L., Forn J. (1986): Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets. Arch. Int. Pharmacodyn. Ther., 284, 155\u2013165.","journal-title":"Arch. Int. Pharmacodyn. Ther."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189970.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03189970\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03189970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T19:23:55Z","timestamp":1635967435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03189970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,10]]}},"alternative-id":["BF03189970"],"URL":"https:\/\/doi.org\/10.1007\/bf03189970","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,10]]}}}